Unknown

Dataset Information

0

Bleeding events in lusutrombopag-treated thrombocytopenic patients.

ABSTRACT:

SUBMITTER: Giannini EG 

PROVIDER: S-EPMC8243945 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Bleeding events in lusutrombopag-treated thrombocytopenic patients.

Giannini Edoardo Giovanni EG   Kano Takeshi T   Ochiai Toshimitsu T   Bentley Roy R   Shrestha Pomy P   Afdhal Nezam N  

European journal of clinical investigation 20210212 6

Similar Datasets

Unknown Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease.
| S-EPMC8799534 | biostudies-literature
Unknown Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants.
| S-EPMC8282556 | biostudies-literature
Unknown Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics.
| S-EPMC10092847 | biostudies-literature
Unknown Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study.
| S-EPMC3049570 | biostudies-literature
Unknown Dynamic prediction of bleeding risk in thrombocytopenic preterm neonates.
| S-EPMC6821634 | biostudies-literature
Unknown Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib.
| S-EPMC4666333 | biostudies-literature
Unknown Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review.
| S-EPMC5568766 | biostudies-literature
Unknown Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients.
| S-EPMC5175165 | biostudies-literature
Unknown Prediction of major bleeding events in 1381 patients with essential thrombocythemia.
| S-EPMC10615906 | biostudies-literature
Unknown Adverse cardiovascular events in patients treated with mogamulizumab.
| S-EPMC10978139 | biostudies-literature